Zobrazeno 1 - 10
of 200
pro vyhledávání: '"Francisco M. Vega"'
Autor:
Aida Amador-Álvarez, María A. Gómez-Muñoz, Ismael Rodríguez-Prieto, Ricardo Pardal, Francisco M. Vega
Publikováno v:
STAR Protocols, Vol 3, Iss 2, Pp 101260- (2022)
Summary: The existence of a subpopulation of undifferentiated cells with stem-like properties has been suggested in neuroblastoma tumors, but a definitive biomarker for their successful isolation is missing. Here we describe an in vitro culture syste
Externí odkaz:
https://doaj.org/article/6ff1e53e59cb4358a60fdae1211844bf
Autor:
María A. Gómez-Muñoz, Diana Aguilar-Morante, Ana Colmenero-Repiso, Aida Amador-Álvarez, Mónica Ojeda-Puertas, Juan Antonio Cordero Varela, Ismael Rodríguez-Prieto, Ricardo Pardal, Francisco M. Vega
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 2, p 1590 (2023)
Neuroblastoma is a neural crest cell-derived pediatric tumor characterized by high inter- and intra-tumor heterogeneity, and by a poor outcome in advanced stages. Patient-derived xenografts (PDXs) have been shown to be useful models for preserving an
Externí odkaz:
https://doaj.org/article/35cf7eebd5e94bf29d778cea0a928c4a
Autor:
Francisco M. Vega, Ana Colmenero-Repiso, María A. Gómez-Muñoz, Ismael Rodríguez-Prieto, Diana Aguilar-Morante, Gema Ramírez, Catalina Márquez, Rosa Cabello, Ricardo Pardal
Publikováno v:
EBioMedicine, Vol 49, Iss , Pp 82-95 (2019)
Background: Neuroblastoma is a paediatric tumour originated from sympathoadrenal precursors and characterized by its heterogeneity and poor outcome in advanced stages. Intra-tumoral cellular heterogeneity has emerged as an important feature in neurob
Externí odkaz:
https://doaj.org/article/b93ece0c075c42bbafdd3defd079033c
Autor:
Francisco M. Vega, Ana Colmenero-Repiso, María A. Gómez-Muñoz, Ismael Rodríguez-Prieto, Diana Aguilar-Morante, Gema Ramírez, Catalina Márquez, Rosa Cabello, Ricardo Pardal
Publikováno v:
EBioMedicine, Vol 53, Iss , Pp - (2020)
Externí odkaz:
https://doaj.org/article/ea43629152854e49bc3d054fc4e1d04e
Autor:
Francisco M. Vega, Ana Colmenero-Repiso, María A. Gómez-Muñoz, Ismael Rodríguez-Prieto, Diana Aguilar-Morante, Gema Ramírez, Catalina Márquez, Rosa Cabello, Ricardo Pardal
Publikováno v:
EBioMedicine, Vol 53, Iss , Pp - (2020)
Externí odkaz:
https://doaj.org/article/a70677f73aa84243ad6a268d155ce076
Publikováno v:
Open Biology, Vol 2, Iss 5 (2012)
The Rho GTPase RhoB has been shown to affect cell migration, but how it does this is not clear. Here we show that cells depleted of RhoB by RNAi are rounded and have defects in Rac-mediated spreading and lamellipodium extension, although they have ac
Externí odkaz:
https://doaj.org/article/a9692e1ed9434dd896207ddec9848c1b
Autor:
Derek Isrow, Juan Pablo Alderuccio, Wei Zhao, Jennifer R. Chapman, Sunil Iyer, Jessica Meshman, Arnold M. Markoe, Izidore S. Lossos, Isildinha M. Reis, Francisco M. Vega
Publikováno v:
Blood
Autor:
Nicolas Gallastegui, Jeremy Ramdial, Francisco M. Vega, Joseph D. Rosenblatt, Amrita Desai, Juan Pablo Alderuccio, Isildinha M. Reis, Wei Zhao, Macarena I. de la Fuente, Erik Kimble, Jennifer R. Chapman, Izidore S. Lossos
Publikováno v:
Journal of Clinical Oncology. 36:3370-3380
Purpose Given the paucity of data on higher-grade transformation (HGT) to aggressive lymphoma in patients with marginal zone lymphoma (MZL), we report on a large cohort of patients, identify risk factors, and determine HGT impact on overall survival
Autor:
Jennifer R. Chapman, Julio Poveda, Izidore S. Lossos, Francisco M. Vega, Juan Pablo Alderuccio, Daniel P. Cassidy, Yi Zhou
Publikováno v:
Leukemialymphoma. 62(5)
We reviewed 341 consecutive cases of marginal zone lymphoma (MZL) (47) or follicular lymphoma (FL) (294) of which 7 were difficult to distinguish due to perceived coexpression of BCL6 and BCL2 by tumor cells in follicular foci. This stimulated us to
Autor:
Dhananjaya Pal, Guillermo A. Morales, Alok R. Singh, Tatiana G. Kutateladze, Adam M. Burgoyne, Kendra R. Vann, Donald L. Durden, Francisco M. Vega, Shweta Joshi, Aran B. Merati
Publikováno v:
Cell Discovery
Cell Discovery, Vol 6, Iss 1, Pp 1-4 (2020)
Digital.CSIC. Repositorio Institucional del CSIC
instname
idUS: Depósito de Investigación de la Universidad de Sevilla
Universidad de Sevilla (US)
idUS. Depósito de Investigación de la Universidad de Sevilla
Cell Discovery, Vol 6, Iss 1, Pp 1-4 (2020)
Digital.CSIC. Repositorio Institucional del CSIC
instname
idUS: Depósito de Investigación de la Universidad de Sevilla
Universidad de Sevilla (US)
idUS. Depósito de Investigación de la Universidad de Sevilla
The PI3K-AKT-mTOR pathway has been at the center of anti-cancer drug development1,2, but targeted inhibition of PI3K kinase activity is proven to provide a limited therapeutic effect and is often followed by the development of resistance to the drug3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7908c1a6f1c38b97a92dc063ea2aa725
http://hdl.handle.net/10261/238737
http://hdl.handle.net/10261/238737